Use of Prescription Opioids Following Surgery and Associated Adverse Patient Outcomes in Older Adults
老年人手术后处方阿片类药物的使用和相关的不良患者结果
基本信息
- 批准号:10017798
- 负责人:
- 金额:$ 67.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAdultAdverse effectsAdverse eventAffectAttentionBehaviorCaringCenters for Disease Control and Prevention (U.S.)CharacteristicsChronicClinicalConduction AnesthesiaDataDependenceDoseElderlyEmergency SituationEpidemicFractureGeneral AnesthesiaHealth systemHospitalizationHospitalsIndividualLabelLeadLocal anesthesiaLong-Term EffectsMeasurementMedicareMethodsNatureOperative Surgical ProceduresOpiate AddictionOpioidPainPain managementPatient-Focused OutcomesPatientsPatternPhysiciansPoliciesPostoperative PainPostoperative PeriodProbabilityProceduresProviderPublic HealthReportingResearchResearch MethodologyResourcesRiskRoleSafetySelection BiasStandardizationSurgeonTechniquesTimeUnited StatesVariantadverse outcomeauthoritybasebeneficiarydesignexperimental studyfallship surgeryhospitalization rateshuman old age (65+)improvedinpatient surgerymortalitynovelopioid epidemicopioid overdoseopioid useoverdose deathpain reductionpain sensationpatient variabilitypeerprescription opioidprescription opioid abuseside effecttreatment durationtrend
项目摘要
Project Summary/Abstract
Rates of opioid prescribing and opioid-related overdose deaths have quadrupled in the United States over
the past 25 years. This epidemic has increasingly affected older adults, among whom hospitalization rates for
opioid overdoses grew five-fold from 1993-2012. Risks of opioid use are particularly pronounced for older
adults, who are vulnerable to opioids’ side effects. Although substantial attention has been placed on
inappropriate prescribing of opioids, the ways in which opioid-naïve patients develop long-term opioid use are
mostly unknown. One of the most common settings for older adults to receive opioids is after surgery. The
period after surgery is a particularly vulnerable one for opioid use, both because of older adults’ clinical fragility
after surgery and because the post-hospitalization period often involves a highly fragmented transition of care.
However, little data exist on the extent to which opioids are prescribed following surgery among older adults,
surgeries for which prescribing and opioid-related adverse events are most common, and the role of surgeon-
and hospital-level factors in contributing to short- and long-term prescription opioid use.
Many argue that variation in physician prescribing behavior has been a driver of the opioid epidemic.
However, no research has explored the extent to which individual surgeons vary in opioid prescribing following
surgery and the implications of that variation for patients’ long-term opioid use and related adverse outcomes.
In addition, little research has examined whether intra- and post-operative pain management techniques such
as regional anesthesia, which may reduce pain following surgery, may also reduce long-term opioid use and
related adverse outcomes after surgery.
The proposed research will quantify the short- and long-term effects of opioid prescribing following surgery
– including short-term opioid-related adverse events and the transition to long-term use – among previously
opioid-naïve older adults who undergo inpatient surgery using Medicare administrative claims. Because a key
challenge in identifying the effect of surgeons in contributing to short- and long-term opioid use after
hospitalization is separating the effects of provider practice patterns from unobservable patient characteristics
that affect opioid use, the proposed research will develop novel quasi-experimental approaches that rely on
quasi-random assignment of hospitalized Medicare beneficiaries to providers of varying opioid-prescribing
intensity. The proposed research will also develop quasi-experimental methods to study how different
approaches to pain management during surgery (use of regional anesthesia) influence post-operative opioid
use and potentially downstream opioid-related adverse outcomes.
Results from this research will help define the risks of post-operative opioid use among older adults and
can inform the need, design and potential impact of policies that target providers to improve the
appropriateness of post-surgical opioid prescribing among older adults.
项目概要/摘要
在美国,阿片类药物处方率和阿片类药物相关过量死亡率已翻了两番
过去25年来,这种流行病对老年人的影响越来越大,其中住院率下降了。
从 1993 年到 2012 年,阿片类药物过量增加了五倍 对于老年人来说,使用阿片类药物的风险尤其明显。
尽管人们对阿片类药物的副作用很敏感,但成年人却很容易受到这种副作用的影响。
阿片类药物处方不当,未使用阿片类药物的患者长期使用阿片类药物的方式是
大多数情况下,老年人接受阿片类药物最常见的情况之一是手术后。
手术后的一段时间是阿片类药物特别容易使用的时期,这都是因为老年人的临床脆弱性
手术后,因为出院后的时期通常涉及高度分散的护理过渡。
然而,关于老年人手术后阿片类药物处方量的数据很少,
处方和阿片类药物相关不良事件最常见的手术,以及外科医生的作用
以及医院层面影响短期和长期处方阿片类药物使用的因素。
许多人认为,医生处方行为的变化是阿片类药物流行的一个驱动因素。
然而,没有研究探讨个体外科医生在阿片类药物处方方面的差异程度
手术以及这种变化对患者长期使用阿片类药物和相关不良后果的影响。
此外,很少有研究探讨术中和术后疼痛管理技术是否
因为局部麻醉可以减轻手术后的疼痛,也可以减少阿片类药物的长期使用,
术后相关不良后果。
拟议的研究将量化手术后阿片类药物处方的短期和长期影响
– 包括短期阿片类药物相关不良事件以及向长期使用的过渡 – 之前
使用医疗保险行政索赔接受住院手术的未使用阿片类药物的老年人是一个关键。
确定外科医生对短期和长期阿片类药物使用的影响是一项挑战
住院治疗将提供者实践模式的影响与不可观察的患者特征分开
影响阿片类药物的使用,拟议的研究将开发依赖于阿片类药物使用的新型准实验方法
将住院医疗保险受益人准随机分配给不同阿片类药物处方的提供者
拟议的研究还将开发准实验方法来研究不同的强度。
手术期间的疼痛管理方法(使用区域麻醉)影响术后阿片类药物
使用和潜在的下游阿片类药物相关的不良后果。
这项研究的结果将有助于确定老年人和老年人术后使用阿片类药物的风险
可以告知针对提供商的政策的需求、设计和潜在影响,以改善
老年人术后阿片类药物处方的适当性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anupam Bapu Jena其他文献
Anupam Bapu Jena的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anupam Bapu Jena', 18)}}的其他基金
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
出院时阿片类药物的处方和相关的不良患者结局
- 批准号:
10018914 - 财政年份:2019
- 资助金额:
$ 67.75万 - 项目类别:
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
出院时阿片类药物的处方和相关的不良患者结局
- 批准号:
10459305 - 财政年份:2019
- 资助金额:
$ 67.75万 - 项目类别:
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
出院时阿片类药物的处方和相关的不良患者结局
- 批准号:
10668243 - 财政年份:2019
- 资助金额:
$ 67.75万 - 项目类别:
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
出院时阿片类药物的处方和相关的不良患者结局
- 批准号:
10225290 - 财政年份:2019
- 资助金额:
$ 67.75万 - 项目类别:
Physician Determinants of Health Care Spending, Quality, and Patient Outcomes
医疗保健支出、质量和患者结果的医生决定因素
- 批准号:
8743315 - 财政年份:2013
- 资助金额:
$ 67.75万 - 项目类别:
Physician Determinants of Health Care Spending, Quality, and Patient Outcomes
医疗保健支出、质量和患者结果的医生决定因素
- 批准号:
8609758 - 财政年份:2013
- 资助金额:
$ 67.75万 - 项目类别:
Physician Determinants of Health Care Spending, Quality, and Patient Outcomes
医疗保健支出、质量和患者结果的医生决定因素
- 批准号:
9135553 - 财政年份:2013
- 资助金额:
$ 67.75万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Vitamin C to Decrease Effects of Smoking during Pregnancy on Offspring Airway Function, Airway Size, and Epigenetic Correlates: VCSIP cohort follow-up through 10 Years of Age
维生素 C 可减少怀孕期间吸烟对后代气道功能、气道大小和表观遗传相关性的影响:VCSIP 队列随访至 10 岁
- 批准号:
10658356 - 财政年份:2023
- 资助金额:
$ 67.75万 - 项目类别:
Prevention of Perinatal Depression in Birthing People with a History of Adverse Childhood Experiences: A Type 2 Effectiveness Implementation Trial
预防有童年不良经历史的出生者的围产期抑郁症:2 类有效性实施试验
- 批准号:
10523685 - 财政年份:2022
- 资助金额:
$ 67.75万 - 项目类别:
Development of an intranasal, direct to nerve treatment for headache disorders
开发鼻内、直接神经治疗头痛疾病
- 批准号:
10382876 - 财政年份:2022
- 资助金额:
$ 67.75万 - 项目类别:
Integrative Training Program for Pediatric Sickle Cell Pain
小儿镰状细胞性疼痛综合训练计划
- 批准号:
10595974 - 财政年份:2022
- 资助金额:
$ 67.75万 - 项目类别:
A digital tool for monitoring speech decline in ALS
用于监测 ALS 言语衰退的数字工具
- 批准号:
10482581 - 财政年份:2022
- 资助金额:
$ 67.75万 - 项目类别: